- Medline (MDLN) announced the pricing of an upsized secondary offering of about 72.6M Class A shares at $37 per share by selling shareholders affiliated with Blackstone (BX), Hellman & Friedman, and a wholly owned subsidiary of Abu Dhabi Investment Authority.
